{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:05:58Z","timestamp":1793563558218,"version":"4.5.0"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of mood, affect, and behavior and abnormalities affecting cognition. Among these conditions, clinical depression, anxiety and neurocognitive disorders are the most common in multiple sclerosis (MS), with a substantial impact on patients\u2019 quality of life and adherence to treatments. Such manifestations may occur from the earliest phases of the disease but become more frequent in MS patients with a progressive disease course and more severe clinical disability. Although the pathogenesis of these neuropsychiatric manifestations has not been fully defined yet, brain structural and functional abnormalities, consistently observed with magnetic resonance imaging (MRI), together with genetic and immunologic factors, have been suggested to be key players. Even though the detrimental clinical impact of such manifestations in MS patients is a matter of crucial importance, at present, they are often overlooked in the clinical setting. Moreover, the efficacy of pharmacologic and non-pharmacologic approaches for their amelioration has been poorly investigated, with the majority of studies showing marginal or no beneficial effect of different therapeutic approaches, possibly due to the presence of multiple and heterogeneous underlying pathological mechanisms and intrinsic methodological limitations. A better evaluation of these manifestations in the clinical setting and improvements in the understanding of their pathophysiology may offer the potential to develop tools for differentiating these mechanisms in individual patients and ultimately provide a principled basis for treatment selection. This review provides an updated overview regarding the pathophysiology of the most common neuropsychiatric symptoms in MS, the clinical and MRI characteristics that have been associated with mood disorders (i.e., depression and anxiety) and cognitive impairment, and the treatment approaches currently available or under investigation.<\/jats:p>","DOI":"10.1038\/s41398-023-02555-7","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T05:18:49Z","timestamp":1689743929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Monica","family":"Margoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-0019","authenticated-orcid":false,"given":"Paolo","family":"Preziosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"2555_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Prim. 2018;4:43.","journal-title":"Nat Rev Dis Prim"},{"key":"2555_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860\u201371.","journal-title":"Lancet Neurol"},{"key":"2555_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015;14:302\u201317.","journal-title":"Lancet Neurol"},{"key":"2555_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/070674370404900302","volume":"49","author":"A Feinstein","year":"2004","unstructured":"Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49:157\u201363.","journal-title":"Can J Psychiatry"},{"key":"2555_CR5","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Prim. 2016;2:16065.","journal-title":"Nat Rev Dis Prim"},{"key":"2555_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0004867413513342","volume":"48","author":"GS Malhi","year":"2014","unstructured":"Malhi GS, Coulston CM, Fritz K, Lampe L, Bargh DM, Ablett M, et al. Unlocking the diagnosis of depression in primary care: which key symptoms are GPs using to determine diagnosis and severity? Aust NZ J Psychiatry. 2014;48:542\u20137.","journal-title":"Aust NZ J Psychiatry"},{"key":"2555_CR7","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312.","journal-title":"Lancet."},{"key":"2555_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","volume":"34","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119\u201338.","journal-title":"Annu Rev Public Health"},{"key":"2555_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators.","year":"2015","unstructured":"Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743\u2013800.","journal-title":"Lancet."},{"key":"2555_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0033-3182(93)71902-7","volume":"34","author":"DS Schubert","year":"1993","unstructured":"Schubert DS, Foliart RH. Increased depression in multiple sclerosis patients. A meta-analysis. Psychosomatics. 1993;34:124\u201330.","journal-title":"Psychosomatics."},{"key":"2555_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8\u201319.","journal-title":"Arch Gen Psychiatry"},{"key":"2555_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, Sorensen PS, Reingold S, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21:263\u201381.","journal-title":"Mult Scler"},{"key":"2555_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","volume":"372","author":"RE Boeschoten","year":"2017","unstructured":"Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331\u201341.","journal-title":"J Neurol Sci"},{"key":"2555_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-16","volume":"13","author":"RA Marrie","year":"2013","unstructured":"Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol. 2013;13:16.","journal-title":"BMC Neurol"},{"key":"2555_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","volume":"11","author":"M Magyari","year":"2020","unstructured":"Magyari M, Sorensen PS. Comorbidity in multiple sclerosis. Front Neurol. 2020;11:851.","journal-title":"Front Neurol"},{"key":"2555_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-0327(87)90062-0","volume":"12","author":"RT Joffe","year":"1987","unstructured":"Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Personal and family history of affective illness in patients with multiple sclerosis. J Affect Disord. 1987;12:63\u201365.","journal-title":"J Affect Disord"},{"key":"2555_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1177\/1352458514540970","volume":"20","author":"V Johansson","year":"2014","unstructured":"Johansson V, Lundholm C, Hillert J, Masterman T, Lichtenstein P, Landen M, et al. Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort. Mult Scler. 2014;20:1881\u201391.","journal-title":"Mult Scler"},{"key":"2555_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1177\/1352458514543344","volume":"20","author":"RA Marrie","year":"2014","unstructured":"Marrie RA. Psychiatric comorbidity in multiple sclerosis: it\u2019s not the genes. Mult Scler. 2014;20:1803\u20135.","journal-title":"Mult Scler"},{"key":"2555_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/135245850000600210","volume":"6","author":"SB Patten","year":"2000","unstructured":"Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler. 2000;6:115\u201320.","journal-title":"Mult Scler"},{"key":"2555_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/135245850000600308","volume":"6","author":"R Bakshi","year":"2000","unstructured":"Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000;6:181\u20135.","journal-title":"Mult Scler"},{"key":"2555_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/135245850100700511","volume":"7","author":"MP Amato","year":"2001","unstructured":"Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7:340\u20134.","journal-title":"Mult Scler"},{"key":"2555_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7224\/1537-2073.2016-110","volume":"20","author":"RA Marrie","year":"2018","unstructured":"Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, et al. Diagnoses of depression and anxiety versus current symptoms and quality of life in multiple sclerosis. Int J MS Care. 2018;20:76\u201384.","journal-title":"Int J MS Care"},{"key":"2555_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1212\/WNL.0000000000000013","volume":"82","author":"SL Minden","year":"2014","unstructured":"Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, et al. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82:174\u201381.","journal-title":"Neurology"},{"key":"2555_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","journal-title":"Arch Gen Psychiatry"},{"key":"2555_CR25","doi-asserted-by":"crossref","unstructured":"Beck A, Steer, R, Brown, GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.","DOI":"10.1037\/t00742-000"},{"key":"2555_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.106.032532","volume":"192","author":"JB Williams","year":"2008","unstructured":"Williams JB, Kobak KA. Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA). Br J Psychiatry. 2008;192:52\u201358.","journal-title":"Br J Psychiatry"},{"key":"2555_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1037\/0894-4105.13.4.546","volume":"13","author":"PA Arnett","year":"1999","unstructured":"Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology. 1999;13:546\u201356.","journal-title":"Neuropsychology."},{"key":"2555_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1037\/0894-4105.13.3.434","volume":"13","author":"PA Arnett","year":"1999","unstructured":"Arnett PA, Higginson CI, Voss WD, Wright B, Bender WI, Wurst JM, et al. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology. 1999;13:434\u201346.","journal-title":"Neuropsychology."},{"key":"2555_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1017\/S1355617701766027","volume":"7","author":"PA Arnett","year":"2001","unstructured":"Arnett PA, Higginson CI, Randolph JJ. Depression in multiple sclerosis: relationship to planning ability. J Int Neuropsychol Soc. 2001;7:665\u201374.","journal-title":"J Int Neuropsychol Soc"},{"key":"2555_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.acn.2007.10.002","volume":"23","author":"BJ Diamond","year":"2008","unstructured":"Diamond BJ, Johnson SK, Kaufman M, Graves L. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol. 2008;23:189\u201399.","journal-title":"Arch Clin Neuropsychol"},{"key":"2555_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ncl.2010.12.003","volume":"29","author":"LJ Julian","year":"2011","unstructured":"Julian LJ. Cognitive functioning in multiple sclerosis. Neurol Clin. 2011;29:507\u201325.","journal-title":"Neurol Clin"},{"key":"2555_CR32","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139\u201351.","journal-title":"Lancet Neurol"},{"key":"2555_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/jpm.2015.0418","volume":"19","author":"J Strupp","year":"2016","unstructured":"Strupp J, Ehmann C, Galushko M, Bucken R, Perrar KM, Hamacher S, et al. Risk factors for suicidal ideation in patients feeling severely affected by multiple sclerosis. J Palliat Med. 2016;19:523\u20138.","journal-title":"J Palliat Med"},{"key":"2555_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/jnnp-2015-310361","volume":"87","author":"A Manouchehrinia","year":"2016","unstructured":"Manouchehrinia A, Tanasescu R, Tench CR, Constantinescu CS. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J Neurol Neurosurg Psychiatry. 2016;87:324\u201331.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2555_CR35","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/ene.13029","volume":"23","author":"P Brenner","year":"2016","unstructured":"Brenner P, Burkill S, Jokinen J, Hillert J, Bahmanyar S, Montgomery S. Multiple sclerosis and risk of attempted and completed suicide - a cohort study. Eur J Neurol. 2016;23:1329\u201336.","journal-title":"Eur J Neurol"},{"key":"2555_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1017\/S1092852900022720","volume":"10","author":"A Feinstein","year":"2005","unstructured":"Feinstein A. The clinical neuropsychiatry of multiple sclerosis. CNS Spectr. 2005;10:362.","journal-title":"CNS Spectr"},{"key":"2555_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.59.5.674","volume":"59","author":"A Feinstein","year":"2002","unstructured":"Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002;59:674\u20138.","journal-title":"Neurology."},{"key":"2555_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","volume":"10","author":"A Feinstein","year":"2014","unstructured":"Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10:507\u201317.","journal-title":"Nat Rev Neurol"},{"key":"2555_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1352458508099478","volume":"15","author":"LJ Julian","year":"2009","unstructured":"Julian LJ, Vella L, Frankel D, Minden SL, Oksenberg JR, Mohr DC. ApoE alleles, depression and positive affect in multiple sclerosis. Mult Scler. 2009;15:311\u20135.","journal-title":"Mult Scler"},{"key":"2555_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/archneur.1992.00530270052018","volume":"49","author":"FW Foley","year":"1992","unstructured":"Foley FW, Traugott U, LaRocca NG, Smith CR, Perlman KR, Caruso LS, et al. A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol. 1992;49:238\u201344.","journal-title":"Arch Neurol"},{"key":"2555_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/archneur.58.7.1081","volume":"58","author":"DC Mohr","year":"2001","unstructured":"Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol. 2001;58:1081\u20136.","journal-title":"Arch Neurol"},{"key":"2555_CR42","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.clineuro.2012.02.048","volume":"114","author":"A Pokryszko-Dragan","year":"2012","unstructured":"Pokryszko-Dragan A, Frydecka I, Kosmaczewska A, Ciszak L, Bilinska M, Gruszka E, et al. Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis. Clin Neurol Neurosurg. 2012;114:1153\u20138.","journal-title":"Clin Neurol Neurosurg"},{"key":"2555_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.iac.2009.02.008","volume":"29","author":"SM Gold","year":"2009","unstructured":"Gold SM, Irwin MR. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am. 2009;29:309\u201320.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2555_CR44","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1007\/s12035-015-9443-4","volume":"53","author":"AP Kallaur","year":"2016","unstructured":"Kallaur AP, Lopes J, Oliveira SR, Simao AN, Reiche EM, de Almeida ER, et al. Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation. Mol Neurobiol. 2016;53:5191\u2013202.","journal-title":"Mol Neurobiol"},{"key":"2555_CR45","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/awp095","volume":"132","author":"L Passamonti","year":"2009","unstructured":"Passamonti L, Cerasa A, Liguori M, Gioia MC, Valentino P, Nistico R, et al. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain. 2009;132:3380\u201391.","journal-title":"Brain."},{"key":"2555_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/135245850000600304","volume":"6","author":"D Berg","year":"2000","unstructured":"Berg D, Supprian T, Thomae J, Warmuth-Metz M, Horowski A, Zeiler B, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler. 2000;6:156\u201362.","journal-title":"Mult Scler"},{"key":"2555_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0925-4927(00)00061-5","volume":"99","author":"J Pujol","year":"2000","unstructured":"Pujol J, Bello J, Deus J, Cardoner N, Marti-Vilalta JL, Capdevila A. Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatry Res. 2000;99:151\u20139.","journal-title":"Psychiatry Res"},{"key":"2555_CR48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1212\/WNL.49.4.1105","volume":"49","author":"J Pujol","year":"1997","unstructured":"Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology. 1997;49:1105\u201310.","journal-title":"Neurology."},{"key":"2555_CR49","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/00001756-200004270-00003","volume":"11","author":"R Bakshi","year":"2000","unstructured":"Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000;11:1153\u20138.","journal-title":"Neuroreport."},{"key":"2555_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol. 1991;50:743\u201355.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2555_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1017\/S0317167100046230","volume":"11","author":"HC Fibiger","year":"1984","unstructured":"Fibiger HC. The neurobiological substrates of depression in Parkinson\u2019s disease: a hypothesis. Can J Neurol Sci. 1984;11:105\u20137.","journal-title":"Can J Neurol Sci"},{"key":"2555_CR52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/mp.2013.20","volume":"18","author":"WD Taylor","year":"2013","unstructured":"Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963\u201374.","journal-title":"Mol Psychiatry"},{"key":"2555_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1352458509355461","volume":"16","author":"A Feinstein","year":"2010","unstructured":"Feinstein A, O\u2019Connor P, Akbar N, Moradzadeh L, Scott CJ, Lobaugh NJ. Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients. Mult Scler. 2010;16:189\u201396.","journal-title":"Mult Scler"},{"key":"2555_CR54","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1177\/1352458517692886","volume":"23","author":"E Pravata","year":"2017","unstructured":"Pravata E, Rocca MA, Valsasina P, Riccitelli GC, Gobbi C, Comi G, et al. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Mult Scler. 2017;23:1864\u201374.","journal-title":"Mult Scler"},{"key":"2555_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12311-019-01096-4","volume":"19","author":"A Lazzarotto","year":"2020","unstructured":"Lazzarotto A, Margoni M, Franciotta S, Zywicki S, Riccardi A, Poggiali D, et al. Selective cerebellar atrophy associates with depression and fatigue in the early phases of relapse-onset multiple sclerosis. Cerebellum. 2020;19:192\u2013200.","journal-title":"Cerebellum."},{"key":"2555_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1352458513493684","volume":"20","author":"C Gobbi","year":"2014","unstructured":"Gobbi C, Rocca MA, Riccitelli G, Pagani E, Messina R, Preziosa P, et al. Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. Mult Scler. 2014;20:192\u2013201.","journal-title":"Mult Scler"},{"key":"2555_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/1352458511403530","volume":"17","author":"G Kiy","year":"2011","unstructured":"Kiy G, Lehmann P, Hahn HK, Eling P, Kastrup A, Hildebrandt H. Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis. Mult Scler. 2011;17:1088\u201397.","journal-title":"Mult Scler"},{"key":"2555_CR58","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/1352458514558474","volume":"21","author":"S Nigro","year":"2015","unstructured":"Nigro S, Passamonti L, Riccelli R, Toschi N, Rocca F, Valentino P, et al. Structural \u2018connectomic\u2019 alterations in the limbic system of multiple sclerosis patients with major depression. Mult Scler. 2015;21:1003\u201312.","journal-title":"Mult Scler"},{"key":"2555_CR59","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1002\/hbm.22992","volume":"36","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Pravata E, Valsasina P, Radaelli M, Colombo B, Vacchi L, et al. Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. Hum Brain Mapp. 2015;36:5051\u201363.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13112","volume":"24","author":"S Bonavita","year":"2017","unstructured":"Bonavita S, Sacco R, Esposito S, d\u2019Ambrosio A, Della Corte M, Corbo D, et al. Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment? Eur J Neurol. 2017;24:27\u201336.","journal-title":"Eur J Neurol"},{"key":"2555_CR61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/01616412.2016.1275460","volume":"39","author":"E Kantorova","year":"2017","unstructured":"Kantorova E, Polacek H, Bittsansky M, Baranovicova E, Hnilicova P, Cierny D, et al. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. Neurol Res. 2017;39:323\u201330.","journal-title":"Neurol Res"},{"key":"2555_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/jnnp-2022-330109","volume":"94","author":"A Carotenuto","year":"2023","unstructured":"Carotenuto A, Valsasina P, Preziosa P, Mistri D, Filippi M, Rocca MA. Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression. J Neurol Neurosurg Psychiatry. 2023;94:94\u2013101.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2555_CR63","doi-asserted-by":"crossref","unstructured":"Fiore A, Preziosa P, Tedone N, Margoni M, Vizzino C, Mistri D, et al. Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis. Mol Psychiatry. 2023;28:1770\u201382.","DOI":"10.1038\/s41380-023-01943-1"},{"key":"2555_CR64","doi-asserted-by":"crossref","unstructured":"Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J. Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev. 2011:CD007295.","DOI":"10.1002\/14651858.CD007295.pub2"},{"key":"2555_CR65","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1176\/ajp.147.11.1493","volume":"147","author":"RB Schiffer","year":"1990","unstructured":"Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry. 1990;147:1493\u20137.","journal-title":"Am J Psychiatry"},{"key":"2555_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.genhosppsych.2007.08.002","volume":"30","author":"DM Ehde","year":"2008","unstructured":"Ehde DM, Kraft GH, Chwastiak L, Sullivan MD, Gibbons LE, Bombardier CH, et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry. 2008;30:40\u20138.","journal-title":"Gen Hosp Psychiatry"},{"key":"2555_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/ane.12648","volume":"134","author":"P Brenner","year":"2016","unstructured":"Brenner P, Piehl F. Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurol Scand. 2016;134:47\u201354.","journal-title":"Acta Neurol Scand"},{"key":"2555_CR68","doi-asserted-by":"publisher","first-page":"427102","DOI":"10.5402\/2012\/427102","volume":"2012","author":"M Skokou","year":"2012","unstructured":"Skokou M, Soubasi E, Gourzis P. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurol. 2012;2012:427102.","journal-title":"ISRN Neurol"},{"key":"2555_CR69","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/WNL.0b013e3181f4d80d","volume":"75","author":"P Grossman","year":"2010","unstructured":"Grossman P, Kappos L, Gensicke H, D\u2019Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010;75:1141\u20139.","journal-title":"Neurology."},{"key":"2555_CR70","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41562-021-01161-1","volume":"5","author":"SH Siddiqi","year":"2021","unstructured":"Siddiqi SH, Schaper F, Horn A, Hsu J, Padmanabhan JL, Brodtmann A, et al. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. Nat Hum Behav. 2021;5:1707\u201316.","journal-title":"Nat Hum Behav"},{"key":"2555_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1590\/S0004-282X2002000500007","volume":"60","author":"MA Lana-Peixoto","year":"2002","unstructured":"Lana-Peixoto MA, Teixeira AL Jr, Haase VG. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis. Arq Neuropsiquiatr. 2002;60:721\u20134.","journal-title":"Arq Neuropsiquiatr"},{"key":"2555_CR72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1191\/1352458505ms1144oa","volume":"11","author":"SB Patten","year":"2005","unstructured":"Patten SB, Francis G, Metz LM, Lopez-Bresnahan M, Chang P, Curtin F. The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis. Mult Scler. 2005;11:175\u201381.","journal-title":"Mult Scler"},{"key":"2555_CR73","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jns.2016.03.024","volume":"365","author":"SF Hunter","year":"2016","unstructured":"Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, et al. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: an analysis from the EPOC (Evaluate Patient OutComes) trial. J Neurol Sci. 2016;365:190\u20138.","journal-title":"J Neurol Sci"},{"key":"2555_CR74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fneur.2015.00097","volume":"6","author":"A Kunkel","year":"2015","unstructured":"Kunkel A, Fischer M, Faiss J, Dahne D, Kohler W, Faiss JH. Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis. Front Neurol. 2015;6:97.","journal-title":"Front Neurol"},{"key":"2555_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13311-019-00781-w","volume":"17","author":"P Preziosa","year":"2020","unstructured":"Preziosa P, Rocca MA, Riccitelli GC, Moiola L, Storelli L, Rodegher M, et al. Effects of natalizumab and fingolimod on clinical, cognitive, and magnetic resonance imaging measures in multiple sclerosis. Neurotherapeutics. 2020;17:208\u201317.","journal-title":"Neurotherapeutics."},{"key":"2555_CR76","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","volume":"397","author":"BW Penninx","year":"2021","unstructured":"Penninx BW, Pine DS, Holmes EA, Reif A. Anxiety disorders. Lancet. 2021;397:914\u201327.","journal-title":"Lancet."},{"key":"2555_CR77","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","volume":"388","author":"MG Craske","year":"2016","unstructured":"Craske MG, Stein MB. Anxiety. Lancet 2016;388:3048\u201359.","journal-title":"Lancet"},{"key":"2555_CR78","doi-asserted-by":"publisher","first-page":"e41910","DOI":"10.1371\/journal.pone.0041910","volume":"7","author":"KH Jones","year":"2012","unstructured":"Jones KH, Ford DV, Jones PA, John A, Middleton RM, Lockhart-Jones H, et al. A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS ONE. 2012;7:e41910.","journal-title":"PLoS ONE"},{"key":"2555_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1037\/rep0000019","volume":"60","author":"N Hartoonian","year":"2015","unstructured":"Hartoonian N, Terrill AL, Beier ML, Turner AP, Day MA, Alschuler KN. Predictors of anxiety in multiple sclerosis. Rehabil Psychol. 2015;60:91\u201398.","journal-title":"Rehabil Psychol"},{"key":"2555_CR80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0404.2010.01436.x","volume":"124","author":"RA Marrie","year":"2011","unstructured":"Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2011;124:135\u201341.","journal-title":"Acta Neurol Scand"},{"key":"2555_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF02340120","volume":"15","author":"E Stenager","year":"1994","unstructured":"Stenager E, Knudsen L, Jensen K. Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction. Ital J Neurol Sci. 1994;15:97\u2013101.","journal-title":"Ital J Neurol Sci"},{"key":"2555_CR82","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.neuropsych.15070167","volume":"28","author":"SA Morrow","year":"2016","unstructured":"Morrow SA, Rosehart H, Pantazopoulos K. Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS. J Neuropsychiatry Clin Neurosci. 2016;28:118\u201323.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2555_CR83","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10072-013-1544-0","volume":"35","author":"B Goretti","year":"2014","unstructured":"Goretti B, Viterbo RG, Portaccio E, Niccolai C, Hakiki B, Piscolla E, et al. Anxiety state affects information processing speed in patients with multiple sclerosis. Neurol Sci. 2014;35:559\u201363.","journal-title":"Neurol Sci"},{"key":"2555_CR84","doi-asserted-by":"publisher","first-page":"102261","DOI":"10.1016\/j.msard.2020.102261","volume":"44","author":"M Hanna","year":"2020","unstructured":"Hanna M, Strober LB. Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261.","journal-title":"Mult Scler Relat Disord"},{"key":"2555_CR85","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/mp.2015.197","volume":"21","author":"T Otowa","year":"2016","unstructured":"Otowa T, Hek K, Lee M, Byrne EM, Mirza SS, Nivard MG, et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol Psychiatry. 2016;21:1391\u20139.","journal-title":"Mol Psychiatry"},{"key":"2555_CR86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","volume":"12","author":"KJ Ressler","year":"2000","unstructured":"Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12:2\u201319.","journal-title":"Depress Anxiety"},{"key":"2555_CR87","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2016.07.024","volume":"284","author":"NP Daskalakis","year":"2016","unstructured":"Daskalakis NP, Cohen H, Nievergelt CM, Baker DG, Buxbaum JD, Russo SJ, et al. New translational perspectives for blood-based biomarkers of PTSD: from glucocorticoid to immune mediators of stress susceptibility. Exp Neurol. 2016;284:133\u201340.","journal-title":"Exp Neurol"},{"key":"2555_CR88","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrn2651","volume":"10","author":"B Roozendaal","year":"2009","unstructured":"Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci. 2009;10:423\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"2555_CR89","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yfrne.2013.12.003","volume":"35","author":"B Myers","year":"2014","unstructured":"Myers B, McKlveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol. 2014;35:180\u201396.","journal-title":"Front Neuroendocrinol"},{"key":"2555_CR90","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1191\/1352458503ms921oa","volume":"9","author":"S Di Legge","year":"2003","unstructured":"Di Legge S, Piattella MC, Pozzilli C, Pantano P, Caramia F, Pestalozza IF, et al. Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis. Mult Scler. 2003;9:302\u20136.","journal-title":"Mult Scler"},{"key":"2555_CR91","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s004150170184","volume":"248","author":"M Zorzon","year":"2001","unstructured":"Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248:416\u201321.","journal-title":"J Neurol"},{"key":"2555_CR92","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/01.wnl.0000201238.93586.d9","volume":"66","author":"MP Sanfilipo","year":"2006","unstructured":"Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology. 2006;66:685\u201392.","journal-title":"Neurology."},{"key":"2555_CR93","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/1352458517711273","volume":"24","author":"M Palotai","year":"2018","unstructured":"Palotai M, Mike A, Cavallari M, Strammer E, Orsi G, Healy BC, et al. Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis. Mult Scler. 2018;24:1105\u201314.","journal-title":"Mult Scler"},{"key":"2555_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tics.2010.11.004","volume":"15","author":"A Etkin","year":"2011","unstructured":"Etkin A, Egner T, Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci. 2011;15:85\u201393.","journal-title":"Trends Cogn Sci"},{"key":"2555_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02476-0","volume":"19","author":"E Ellwardt","year":"2022","unstructured":"Ellwardt E, Muthuraman M, Gonzalez-Escamilla G, Chirumamilla VC, Luessi F, Bittner S, et al. Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation. 2022;19:119.","journal-title":"J Neuroinflammation"},{"key":"2555_CR96","doi-asserted-by":"publisher","first-page":"e93432","DOI":"10.1371\/journal.pone.0093432","volume":"9","author":"J Shang","year":"2014","unstructured":"Shang J, Fu Y, Ren Z, Zhang T, Du M, Gong Q, et al. The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies. PLoS ONE. 2014;9:e93432.","journal-title":"PLoS ONE"},{"key":"2555_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pscychresns.2017.08.004","volume":"268","author":"C Andreescu","year":"2017","unstructured":"Andreescu C, Tudorascu D, Sheu LK, Rangarajan A, Butters MA, Walker S, et al. Brain structural changes in late-life generalized anxiety disorder. Psychiatry Res Neuroimaging. 2017;268:15\u201321.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2555_CR98","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jad.2012.11.060","volume":"148","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Li L, Yu R, Liu J, Tang J, Tan L, et al. White matter integrity alterations in first episode, treatment-naive generalized anxiety disorder. J Affect Disord. 2013;148:196\u2013201.","journal-title":"J Affect Disord"},{"key":"2555_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-41","volume":"14","author":"M Liao","year":"2014","unstructured":"Liao M, Yang F, Zhang Y, He Z, Su L, Li L. White matter abnormalities in adolescents with generalized anxiety disorder: a diffusion tensor imaging study. BMC Psychiatry. 2014;14:41.","journal-title":"BMC Psychiatry"},{"key":"2555_CR100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbr.2016.08.017","volume":"314","author":"W Wang","year":"2016","unstructured":"Wang W, Qian S, Liu K, Li B, Li M, Xin K, et al. Reduced white matter integrity and its correlation with clinical symptom in first-episode, treatment-naive generalized anxiety disorder. Behav Brain Res. 2016;314:159\u201364.","journal-title":"Behav Brain Res"},{"key":"2555_CR101","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/archpsyc.65.5.568","volume":"65","author":"CS Monk","year":"2008","unstructured":"Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, et al. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry. 2008;65:568\u201376.","journal-title":"Arch Gen Psychiatry"},{"key":"2555_CR102","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1093\/brain\/awu101","volume":"137","author":"E Carrera","year":"2014","unstructured":"Carrera E, Tononi G. Diaschisis: past, present, future. Brain 2014;137:2408\u201322.","journal-title":"Brain"},{"key":"2555_CR103","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.nicl.2019.102016","volume":"24","author":"TA Kolesar","year":"2019","unstructured":"Kolesar TA, Bilevicius E, Wilson AD, Kornelsen J. Systematic review and meta-analyses of neural structural and functional differences in generalized anxiety disorder and healthy controls using magnetic resonance imaging. Neuroimage Clin. 2019;24:102016.","journal-title":"Neuroimage Clin"},{"key":"2555_CR104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2015.10.004","volume":"5","author":"KM Fiest","year":"2016","unstructured":"Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12\u201326.","journal-title":"Mult Scler Relat Disord"},{"key":"2555_CR105","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/ane.12833","volume":"137","author":"I Rorsman","year":"2018","unstructured":"Rorsman I, Petersen C, Nilsson PC. Cognitive functioning following one-year natalizumab treatment: a non-randomized clinical trial. Acta Neurol Scand. 2018;137:117\u201324.","journal-title":"Acta Neurol Scand"},{"key":"2555_CR106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7224\/1537-2073.2015-033","volume":"18","author":"RA Sater","year":"2016","unstructured":"Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater P. NAPS-MS: natalizumab effects on parameters of sleep in patients with multiple sclerosis. Int J MS Care. 2016;18:177\u201382.","journal-title":"Int J MS Care."},{"key":"2555_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000451077","volume":"77","author":"T Moreau","year":"2017","unstructured":"Moreau T, Bungener C, Heinzlef O, Suchet L, Borgel F, Bourdeix I, et al. Anxiety and coping strategy changes in multiple sclerosis patients initiating fingolimod: the GRACE prospective study. Eur Neurol. 2017;77:47\u201355.","journal-title":"Eur Neurol"},{"key":"2555_CR108","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2017;23:1258\u201367.","journal-title":"Mult Scler"},{"key":"2555_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.0b013e31824528c9","volume":"78","author":"MP Amato","year":"2012","unstructured":"Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, et al. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology. 2012;78:309\u201314.","journal-title":"Neurology."},{"key":"2555_CR110","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaneurol.2019.1546","volume":"76","author":"KA McKay","year":"2019","unstructured":"McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis. JAMA Neurol. 2019;76:1028\u201334.","journal-title":"JAMA Neurol"},{"key":"2555_CR111","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1017\/S1355617708080624","volume":"14","author":"JA Duquin","year":"2008","unstructured":"Duquin JA, Parmenter BA, Benedict RH. Influence of recruitment and participation bias in neuropsychological research among MS patients. J Int Neuropsychol Soc. 2008;14:494\u20138.","journal-title":"J Int Neuropsychol Soc"},{"key":"2555_CR112","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1002\/hbm.22332","volume":"35","author":"MM Schoonheim","year":"2014","unstructured":"Schoonheim MM, Vigeveno RM, Rueda Lopes FC, Pouwels PJ, Polman CH, Barkhof F, et al. Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp. 2014;35:2348\u201358.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR113","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1212\/WNL.0b013e3182703f46","volume":"79","author":"MM Schoonheim","year":"2012","unstructured":"Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, et al. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 2012;79:1754\u201361.","journal-title":"Neurology"},{"key":"2555_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1352458511422245","volume":"18","author":"MM Schoonheim","year":"2012","unstructured":"Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, et al. Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler. 2012;18:164\u201373.","journal-title":"Mult Scler"},{"key":"2555_CR115","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.neubiorev.2017.09.005","volume":"83","author":"A Johnen","year":"2017","unstructured":"Johnen A, Landmeyer NC, Burkner PC, Wiendl H, Meuth SG, Holling H. Distinct cognitive impairments in different disease courses of multiple sclerosis-a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;83:568\u201378.","journal-title":"Neurosci Biobehav Rev"},{"key":"2555_CR116","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/1352458510375707","volume":"16","author":"C Lebrun","year":"2010","unstructured":"Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J, CFSEP. Cognitive function in radiologically isolated syndrome. Mult Scler. 2010;16:919\u201325.","journal-title":"Mult Scler"},{"key":"2555_CR117","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0000000000000309","volume":"82","author":"MA Rocca","year":"2014","unstructured":"Rocca MA, Absinta M, Amato MP, Moiola L, Ghezzi A, Veggiotti P, et al. Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. Neurology. 2014;82:1314\u201321.","journal-title":"Neurology."},{"key":"2555_CR118","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1212\/01.wnl.0000312276.23177.fa","volume":"70","author":"MP Amato","year":"2008","unstructured":"Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology. 2008;70:1891\u20137.","journal-title":"Neurology."},{"key":"2555_CR119","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1212\/WNL.0000000000003028","volume":"87","author":"A Waldman","year":"2016","unstructured":"Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP, et al. Pediatric multiple sclerosis: clinical features and outcome. Neurology. 2016;87:S74\u201381.","journal-title":"Neurology."},{"key":"2555_CR120","first-page":"563989","volume":"2012","author":"S Ozakbas","year":"2012","unstructured":"Ozakbas S, Kaya D, Idiman E. Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging. Autoimmune Dis. 2012;2012:563989.","journal-title":"Autoimmune Dis"},{"key":"2555_CR121","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rehab.2018.01.006","volume":"63","author":"A Ruet","year":"2020","unstructured":"Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: from neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. 2020;63:154\u20138.","journal-title":"Ann Phys Rehabil Med"},{"key":"2555_CR122","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18:891\u20138.","journal-title":"Mult Scler"},{"key":"2555_CR123","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458518808204","volume":"25","author":"L Strober","year":"2019","unstructured":"Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N, et al. Symbol Digit Modalities Test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis. Mult Scler. 2019;25:1781\u201390.","journal-title":"Mult Scler"},{"key":"2555_CR124","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","volume":"58","author":"MP Amato","year":"2001","unstructured":"Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol. 2001;58:1602\u20136.","journal-title":"Arch Neurol"},{"key":"2555_CR125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.msard.2014.03.004","volume":"3","author":"LB Strober","year":"2014","unstructured":"Strober LB, Rao SM, Lee JC, Fischer E, Rudick R. Cognitive impairment in multiple sclerosis: an 18 year follow-up study. Mult Scler Relat Disord. 2014;3:473\u201381.","journal-title":"Mult Scler Relat Disord"},{"key":"2555_CR126","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2007.01.070","volume":"255","author":"SR Schwid","year":"2007","unstructured":"Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP, Copaxone Study Group. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci. 2007;255:57\u201363.","journal-title":"J Neurol Sci"},{"key":"2555_CR127","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00415-018-8747-5","volume":"265","author":"VM Leavitt","year":"2018","unstructured":"Leavitt VM, Tosto G, Riley CS. Cognitive phenotypes in multiple sclerosis. J Neurol. 2018;265:562\u20136.","journal-title":"J Neurol"},{"key":"2555_CR128","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/ene.14186","volume":"27","author":"J Zurawski","year":"2020","unstructured":"Zurawski J, Healy BC, Ratajska A, Barker L, Glanz BI, Houtchens M. Identification of a predominant cognitive phenotype in patients with multiple sclerosis. Eur J Neurol. 2020;27:1083\u20138.","journal-title":"Eur J Neurol"},{"key":"2555_CR129","doi-asserted-by":"crossref","unstructured":"Hancock LM, Galioto R, Samsonov A, Busch RM, Hermann B, Matias-Guiu JA. A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS). Mult Scler. 2022:29:615\u201327.","DOI":"10.1177\/13524585221127941"},{"key":"2555_CR130","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamaneurol.2020.4920","volume":"78","author":"E De Meo","year":"2021","unstructured":"De Meo E, Portaccio E, Giorgio A, Ruano L, Goretti B, Niccolai C, et al. Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol. 2021;78:414\u201325.","journal-title":"JAMA Neurol"},{"key":"2555_CR131","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","volume":"10","author":"PS Sachdev","year":"2014","unstructured":"Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. 2014;10:634\u201342.","journal-title":"Nat Rev Neurol"},{"key":"2555_CR132","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern Y. Cognitive reserve. Neuropsychologia. 2009;47:2015\u201328.","journal-title":"Neuropsychologia."},{"key":"2555_CR133","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1148\/radiology.216.3.r00au37672","volume":"216","author":"E Courchesne","year":"2000","unstructured":"Courchesne E, Chisum HJ, Townsend J, Cowles A, Covington J, Egaas B, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology. 2000;216:672\u201382.","journal-title":"Radiology."},{"key":"2555_CR134","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1212\/WNL.0b013e318296e98b","volume":"80","author":"JF Sumowski","year":"2013","unstructured":"Sumowski JF, Rocca MA, Leavitt VM, Riccitelli G, Comi G, DeLuca J, et al. Brain reserve and cognitive reserve in multiple sclerosis: what you\u2019ve got and how you use it. Neurology. 2013;80:2186\u201393.","journal-title":"Neurology."},{"key":"2555_CR135","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448\u201360.","journal-title":"J Int Neuropsychol Soc"},{"key":"2555_CR136","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1212\/WNL.0b013e3181e396be","volume":"74","author":"JF Sumowski","year":"2010","unstructured":"Sumowski JF, Wylie GR, Chiaravalloti N, DeLuca J. Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology. 2010;74:1942\u20135.","journal-title":"Neurology."},{"key":"2555_CR137","doi-asserted-by":"publisher","first-page":"e87567","DOI":"10.1371\/journal.pone.0087567","volume":"9","author":"D Pinter","year":"2014","unstructured":"Pinter D, Sumowski J, DeLuca J, Fazekas F, Pichler A, Khalil M, et al. Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis. PLoS ONE. 2014;9:e87567.","journal-title":"PLoS ONE"},{"key":"2555_CR138","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1212\/WNL.0b013e3182918c6f","volume":"80","author":"MP Amato","year":"2013","unstructured":"Amato MP, Razzolini L, Goretti B, Stromillo ML, Rossi F, Giorgio A, et al. Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. Neurology. 2013;80:1728\u201333.","journal-title":"Neurology."},{"key":"2555_CR139","doi-asserted-by":"publisher","first-page":"e47206","DOI":"10.1371\/journal.pone.0047206","volume":"7","author":"O Ghaffar","year":"2012","unstructured":"Ghaffar O, Fiati M, Feinstein A. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS ONE. 2012;7:e47206.","journal-title":"PLoS ONE"},{"key":"2555_CR140","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/13803390902740643","volume":"31","author":"JF Sumowski","year":"2009","unstructured":"Sumowski JF, Chiaravalloti N, DeLuca J. Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsychol. 2009;31:913\u201326.","journal-title":"J Clin Exp Neuropsychol"},{"key":"2555_CR141","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1212\/WNL.0b013e3181f881a6","volume":"75","author":"JF Sumowski","year":"2010","unstructured":"Sumowski JF, Wylie GR, Gonnella A, Chiaravalloti N, Deluca J. Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis. Neurology. 2010;75:1428\u201331.","journal-title":"Neurology."},{"key":"2555_CR142","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1177\/1352458512440205","volume":"18","author":"JF Sumowski","year":"2012","unstructured":"Sumowski JF, Chiaravalloti N, Leavitt VM, Deluca J. Cognitive reserve in secondary progressive multiple sclerosis. Mult Scler. 2012;18:1454\u20138.","journal-title":"Mult Scler"},{"key":"2555_CR143","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1177\/1352458516629559","volume":"22","author":"L Pasto","year":"2016","unstructured":"Pasto L, Portaccio E, Goretti B, Ghezzi A, Lori S, Hakiki B, et al. The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis. Mult Scler. 2016;22:1741\u20139.","journal-title":"Mult Scler"},{"key":"2555_CR144","doi-asserted-by":"publisher","first-page":"102145","DOI":"10.1016\/j.msard.2020.102145","volume":"42","author":"E Portaccio","year":"2020","unstructured":"Portaccio E, Simone M, Prestipino E, Bellinvia A, Past\u00f2 L, Niccolai M, et al. Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis. Mult Scler Relat Disord. 2020;42:102145.","journal-title":"Mult Scler Relat Disord"},{"key":"2555_CR145","doi-asserted-by":"publisher","first-page":"e1626","DOI":"10.1212\/WNL.0000000000200115","volume":"98","author":"E Portaccio","year":"2022","unstructured":"Portaccio E, Bellinvia A, Razzolini L, Pasto L, Goretti B, Niccolai C, et al. Long-term cognitive outcomes and socioprofessional attainment in people with multiple sclerosis with childhood onset. Neurology. 2022;98:e1626\u201336.","journal-title":"Neurology."},{"key":"2555_CR146","doi-asserted-by":"crossref","unstructured":"Chiang HS, Khera A, Stopschinski BE, Stuve O, Hart J, Jr, Kelley B, et al. Cognitive decline in older people with multiple sclerosis-a narrative review of the literature. Geriatrics. 2022;7:61.","DOI":"10.3390\/geriatrics7030061"},{"key":"2555_CR147","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1076\/clin.16.4.472.13904","volume":"16","author":"WW Beatty","year":"2002","unstructured":"Beatty WW, Aupperle RL. Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol. 2002;16:472\u201380.","journal-title":"Clin Neuropsychol"},{"key":"2555_CR148","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","volume":"90","author":"JF Sumowski","year":"2018","unstructured":"Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, et al. Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology. 2018;90:278\u201388.","journal-title":"Neurology."},{"key":"2555_CR149","doi-asserted-by":"crossref","unstructured":"Macias Islas MA, Ciampi E. Assessment and impact of cognitive impairment in multiple sclerosis: an overview. Biomedicines. 2019;7:22.","DOI":"10.3390\/biomedicines7010022"},{"key":"2555_CR150","doi-asserted-by":"publisher","first-page":"671894","DOI":"10.3389\/fneur.2021.671894","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Cortese R, De Stefano N, Giorgio A. Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis. Front Neurol. 2021;12:671894.","journal-title":"Front Neurol"},{"key":"2555_CR151","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fnhum.2018.00138","volume":"12","author":"Y Liu","year":"2018","unstructured":"Liu Y, Duan Y, Dong H, Barkhof F, Li K, Shu N. Disrupted module efficiency of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis. Front Hum Neurosci. 2018;12:138.","journal-title":"Front Hum Neurosci"},{"key":"2555_CR152","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncel.2019.00021","volume":"13","author":"G Savini","year":"2019","unstructured":"Savini G, Pardini M, Castellazzi G, Lascialfari A, Chard D, D\u2019Angelo E, et al. Default mode network structural integrity and cerebellar connectivity predict information processing speed deficit in multiple sclerosis. Front Cell Neurosci. 2019;13:21.","journal-title":"Front Cell Neurosci"},{"key":"2555_CR153","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.nicl.2016.11.026","volume":"13","author":"S Llufriu","year":"2017","unstructured":"Llufriu S, Martinez-Heras E, Solana E, Sola-Valls N, Sepulveda M, Blanco Y, et al. Structural networks involved in attention and executive functions in multiple sclerosis. Neuroimage Clin. 2017;13:288\u201396.","journal-title":"Neuroimage Clin"},{"key":"2555_CR154","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.nicl.2020.102177","volume":"25","author":"AC Has Silemek","year":"2020","unstructured":"Has Silemek AC, Fischer L, Pottgen J, Penner IK, Engel AK, Heesen C, et al. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability. Neuroimage Clin. 2020;25:102177.","journal-title":"Neuroimage Clin"},{"key":"2555_CR155","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1212\/WNL.0b013e31824d5859","volume":"78","author":"S Mesaros","year":"2012","unstructured":"Mesaros S, Rocca MA, Kacar K, Kostic J, Copetti M, Stosic-Opincal T, et al. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology. 2012;78:969\u201375.","journal-title":"Neurology."},{"key":"2555_CR156","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.neuroimage.2007.04.038","volume":"36","author":"B Audoin","year":"2007","unstructured":"Audoin B, Guye M, Reuter F, Au Duong MV, Confort-Gouny S, Malikova I, et al. Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. Neuroimage. 2007;36:1324\u201330.","journal-title":"Neuroimage."},{"key":"2555_CR157","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1002\/hbm.20692","volume":"30","author":"S Mesaros","year":"2009","unstructured":"Mesaros S, Rocca MA, Riccitelli G, Pagani E, Rovaris M, Caputo D, et al. Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp. 2009;30:2656\u201366.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR158","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hbm.20504","volume":"30","author":"MA Rocca","year":"2009","unstructured":"Rocca MA, Valsasina P, Ceccarelli A, Absinta M, Ghezzi A, Riccitelli G, et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp. 2009;30:276\u201390.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR159","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2005.04.019","volume":"237","author":"X Lin","year":"2005","unstructured":"Lin X, Tench CR, Morgan PS, Niepel G, Constantinescu CS. \u2018Importance sampling\u2019 in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment. J Neurol Sci. 2005;237:13\u201319.","journal-title":"J Neurol Sci"},{"key":"2555_CR160","doi-asserted-by":"publisher","first-page":"e37167","DOI":"10.1371\/journal.pone.0037167","volume":"7","author":"S Llufriu","year":"2012","unstructured":"Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, et al. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study. PLoS ONE. 2012;7:e37167.","journal-title":"PLoS ONE"},{"key":"2555_CR161","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1352458509353649","volume":"16","author":"A Ozturk","year":"2010","unstructured":"Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, et al. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler. 2010;16:166\u201377.","journal-title":"Mult Scler"},{"key":"2555_CR162","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awn275","volume":"132","author":"RA Dineen","year":"2009","unstructured":"Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain. 2009;132:239\u201349.","journal-title":"Brain."},{"key":"2555_CR163","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neuroimage.2008.10.026","volume":"44","author":"SD Roosendaal","year":"2009","unstructured":"Roosendaal SD, Geurts JJ, Vrenken H, Hulst HE, Cover KS, Castelijns JA, et al. Regional DTI differences in multiple sclerosis patients. Neuroimage. 2009;44:1397\u2013403.","journal-title":"Neuroimage."},{"key":"2555_CR164","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31828726cc","volume":"80","author":"HE Hulst","year":"2013","unstructured":"Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, et al. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology. 2013;80:1025\u201332.","journal-title":"Neurology."},{"key":"2555_CR165","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/hbm.23125","volume":"37","author":"P Preziosa","year":"2016","unstructured":"Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, et al. Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: a multicenter study. Hum Brain Mapp. 2016;37:1627\u201344.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR166","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/1352458513503722","volume":"20","author":"S Llufriu","year":"2014","unstructured":"Llufriu S, Martinez-Heras E, Fortea J, Blanco Y, Berenguer J, Gabilondo I, et al. Cognitive functions in multiple sclerosis: impact of gray matter integrity. Mult Scler. 2014;20:424\u201332.","journal-title":"Mult Scler"},{"key":"2555_CR167","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jmri.21294","volume":"27","author":"SD Roosendaal","year":"2008","unstructured":"Roosendaal SD, Moraal B, Vrenken H, Castelijns JA, Pouwels PJ, Barkhof F, et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging. 2008;27:726\u201331.","journal-title":"J Magn Reson Imaging"},{"key":"2555_CR168","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66:1144\u201350.","journal-title":"Arch Neurol"},{"key":"2555_CR169","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1212\/WNL.0b013e3182a08ce8","volume":"81","author":"AS Nielsen","year":"2013","unstructured":"Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology. 2013;81:641\u20139.","journal-title":"Neurology."},{"key":"2555_CR170","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain. 2012;135:2952\u201361.","journal-title":"Brain."},{"key":"2555_CR171","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3174\/ajnr.A4952","volume":"38","author":"D Damjanovic","year":"2017","unstructured":"Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, et al. Hippocampal and deep gray matter nuclei atrophy is relevant for explaining cognitive impairment in MS: a multicenter study. AJNR Am J Neuroradiol. 2017;38:18\u201324.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2555_CR172","doi-asserted-by":"publisher","first-page":"e1348","DOI":"10.1212\/WNL.0000000000008198","volume":"93","author":"AJC Eijlers","year":"2019","unstructured":"Eijlers AJC, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Pouwels PJW, et al. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis. Neurology. 2019;93:e1348\u201359.","journal-title":"Neurology."},{"key":"2555_CR173","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1212\/01.wnl.0000276992.17011.b5","volume":"69","author":"MK Houtchens","year":"2007","unstructured":"Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology. 2007;69:1213\u201323.","journal-title":"Neurology."},{"key":"2555_CR174","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00429-013-0665-9","volume":"220","author":"G Longoni","year":"2015","unstructured":"Longoni G, Rocca MA, Pagani E, Riccitelli GC, Colombo B, Rodegher M, et al. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. Brain Struct Funct. 2015;220:435\u201344.","journal-title":"Brain Struct Funct"},{"key":"2555_CR175","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/WNL.0000000000001285","volume":"84","author":"MM Schoonheim","year":"2015","unstructured":"Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, et al. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 2015;84:776\u201383.","journal-title":"Neurology."},{"key":"2555_CR176","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/brain\/awn030","volume":"131","author":"NL Sicotte","year":"2008","unstructured":"Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain. 2008;131:1134\u201341.","journal-title":"Brain."},{"key":"2555_CR177","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","volume":"81","author":"M Filippi","year":"2013","unstructured":"Filippi M, Preziosa P, Copetti M, Riccitelli G, Horsfield MA, Martinelli V, et al. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology. 2013;81:1759\u201367.","journal-title":"Neurology."},{"key":"2555_CR178","first-page":"2605","volume":"141","author":"AJC Eijlers","year":"2018","unstructured":"Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, et al. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain. 2018;141:2605\u201318.","journal-title":"Brain."},{"key":"2555_CR179","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2008.12.019","volume":"282","author":"J Sastre-Garriga","year":"2009","unstructured":"Sastre-Garriga J, Arevalo MJ, Renom M, Alonso J, Gonzalez I, Galan I, et al. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. J Neurol Sci. 2009;282:120\u20134.","journal-title":"J Neurol Sci"},{"key":"2555_CR180","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11682-012-9170-7","volume":"8","author":"U Nocentini","year":"2014","unstructured":"Nocentini U, Bozzali M, Spano B, Cercignani M, Serra L, Basile B, et al. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis. Brain Imaging Behav. 2014;8:378\u201386.","journal-title":"Brain Imaging Behav"},{"key":"2555_CR181","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11682-016-9667-6","volume":"12","author":"A Bisecco","year":"2018","unstructured":"Bisecco A, Stamenova S, Caiazzo G, d\u2019Ambrosio A, Sacco R, Docimo R, et al. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume. Brain Imaging Behav. 2018;12:20\u201328.","journal-title":"Brain Imaging Behav"},{"key":"2555_CR182","doi-asserted-by":"crossref","unstructured":"Tedone N, Preziosa P, Meani A, Pagani E, Vizzino C, Filippi M, et al. Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex. Mol Psychiatry. 2023;28:1783\u201392.","DOI":"10.1038\/s41380-023-01996-2"},{"key":"2555_CR183","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/hbm.10128","volume":"20","author":"B Audoin","year":"2003","unstructured":"Audoin B, Ibarrola D, Ranjeva JP, Confort-Gouny S, Malikova I, Ali-Cherif A, et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp. 2003;20:51\u20138.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR184","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neuroimage.2003.10.004","volume":"21","author":"C Mainero","year":"2004","unstructured":"Mainero C, Caramia F, Pozzilli C, Pisani A, Pestalozza I, Borriello G, et al. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage. 2004;21:858\u201367.","journal-title":"Neuroimage."},{"key":"2555_CR185","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00415-003-1025-0","volume":"250","author":"IK Penner","year":"2003","unstructured":"Penner IK, Rausch M, Kappos L, Opwis K, Radu EW. Analysis of impairment related functional architecture in MS patients during performance of different attention tasks. J Neurol. 2003;250:461\u201372.","journal-title":"J Neurol"},{"key":"2555_CR186","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3174\/ajnr.A2071","volume":"31","author":"MA Rocca","year":"2010","unstructured":"Rocca MA, Riccitelli G, Rodegher M, Ceccarelli A, Falini A, Falautano M, et al. Functional MR imaging correlates of neuropsychological impairment in primary-progressive multiple sclerosis. AJNR Am J Neuroradiol. 2010;31:1240\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2555_CR187","doi-asserted-by":"publisher","first-page":"e93715","DOI":"10.1371\/journal.pone.0093715","volume":"9","author":"M Loitfelder","year":"2014","unstructured":"Loitfelder M, Fazekas F, Koschutnig K, Fuchs S, Petrovic K, Ropele S, et al. Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study. PLoS ONE. 2014;9:e93715.","journal-title":"PLoS ONE"},{"key":"2555_CR188","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/brain\/awh670","volume":"129","author":"S Cader","year":"2006","unstructured":"Cader S, Cifelli A, Abu-Omar Y, Palace J, Matthews PM. Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain. 2006;129:527\u201337.","journal-title":"Brain."},{"key":"2555_CR189","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1212\/WNL.0b013e31820b75cf","volume":"76","author":"M Loitfelder","year":"2011","unstructured":"Loitfelder M, Fazekas F, Petrovic K, Fuchs S, Ropele S, Wallner-Blazek M, et al. Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI. Neurology. 2011;76:526\u201333.","journal-title":"Neurology."},{"key":"2555_CR190","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1002\/hbm.22586","volume":"35","author":"MA Rocca","year":"2014","unstructured":"Rocca MA, Valsasina P, Hulst HE, Abdel-Aziz K, Enzinger C, Gallo A, et al. Functional correlates of cognitive dysfunction in multiple sclerosis: a multicenter fMRI study. Hum Brain Mapp. 2014;35:5799\u2013814.","journal-title":"Hum Brain Mapp"},{"key":"2555_CR191","doi-asserted-by":"publisher","first-page":"e42862","DOI":"10.1371\/journal.pone.0042862","volume":"7","author":"M Loitfelder","year":"2012","unstructured":"Loitfelder M, Filippi M, Rocca M, Valsasina P, Ropele S, Jehna M, et al. Abnormalities of resting state functional connectivity are related to sustained attention deficits in MS. PLoS ONE. 2012;7:e42862.","journal-title":"PLoS ONE"},{"key":"2555_CR192","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1352458508089360","volume":"14","author":"B Audoin","year":"2008","unstructured":"Audoin B, Reuter F, Duong MV, Malikova I, Confort-Gouny S, Cherif AA, et al. Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study. Mult Scler. 2008;14:786\u201392.","journal-title":"Mult Scler"},{"key":"2555_CR193","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1212\/WNL.0b013e3181d9ed91","volume":"74","author":"MA Rocca","year":"2010","unstructured":"Rocca MA, Valsasina P, Absinta M, Riccitelli G, Rodegher ME, Misci P, et al. Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology. 2010;74:1252\u20139.","journal-title":"Neurology."},{"key":"2555_CR194","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1352458510394609","volume":"17","author":"S Bonavita","year":"2011","unstructured":"Bonavita S, Gallo A, Sacco R, Corte MD, Bisecco A, Docimo R, et al. Distributed changes in default-mode resting-state connectivity in multiple sclerosis. Mult Scler. 2011;17:411\u201322.","journal-title":"Mult Scler"},{"key":"2555_CR195","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1073\/pnas.1110024108","volume":"108","author":"DJ Hawellek","year":"2011","unstructured":"Hawellek DJ, Hipp JF, Lewis CM, Corbetta M, Engel AK. Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis. Proc Natl Acad Sci USA. 2011;108:19066\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2555_CR196","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1177\/1352458511435930","volume":"18","author":"A Faivre","year":"2012","unstructured":"Faivre A, Rico A, Zaaraoui W, Crespy L, Reuter F, Wybrecht D, et al. Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis. Mult Scler. 2012;18:1251\u20138.","journal-title":"Mult Scler"},{"key":"2555_CR197","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00415-020-10025-z","volume":"267","author":"GC Riccitelli","year":"2020","unstructured":"Riccitelli GC, Pagani E, Meani A, Valsasina P, Preziosa P, Filippi M, et al. Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study. J Neurol. 2020;267:3508\u201317.","journal-title":"J Neurol"},{"key":"2555_CR198","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1148\/radiol.2018172808","volume":"288","author":"AJC Eijlers","year":"2018","unstructured":"Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM. Determinants of cognitive impairment in patients with multiple sclerosis with and without atrophy. Radiology. 2018;288:544\u201351.","journal-title":"Radiology."},{"key":"2555_CR199","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp-2021-327803","volume":"93","author":"P Preziosa","year":"2022","unstructured":"Preziosa P, Pagani E, Bonacchi R, Cacciaguerra L, Falini A, Rocca MA, et al. In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI. J Neurol Neurosurg Psychiatry. 2022;93:628\u201336.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2555_CR200","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00415-020-10331-6","volume":"268","author":"L Conti","year":"2021","unstructured":"Conti L, Riccitelli GC, Preziosa P, Vizzino C, Marchesi O, Rocca MA, et al. Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment. J Neurol. 2021;268:1780\u201391.","journal-title":"J Neurol"},{"key":"2555_CR201","doi-asserted-by":"publisher","unstructured":"Azzimonti M, Preziosa P, Pagani E, Valsasina P, Tedone N, Vizzino C, et al. Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study. J Neurol. 2023. https:\/\/doi.org\/10.1007\/s00415-023-11778-z.","DOI":"10.1007\/s00415-023-11778-z"},{"key":"2555_CR202","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00415-021-10832-y","volume":"269","author":"P Preziosa","year":"2022","unstructured":"Preziosa P, Conti L, Rocca MA, Filippi M. Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity. J Neurol. 2022;269:1052\u201364.","journal-title":"J Neurol"},{"key":"2555_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2015.05.004","volume":"354","author":"M Mitolo","year":"2015","unstructured":"Mitolo M, Venneri A, Wilkinson ID, Sharrack B. Cognitive rehabilitation in multiple sclerosis: a systematic review. J Neurol Sci. 2015;354:1\u20139.","journal-title":"J Neurol Sci"},{"key":"2555_CR204","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/0269215517722583","volume":"32","author":"JR Mhizha-Murira","year":"2018","unstructured":"Mhizha-Murira JR, Drummond A, Klein OA, dasNair R. Reporting interventions in trials evaluating cognitive rehabilitation in people with multiple sclerosis: a systematic review. Clin Rehabil. 2018;32:243\u201354.","journal-title":"Clin Rehabil"},{"key":"2555_CR205","doi-asserted-by":"crossref","unstructured":"Rosti-Otajarvi EM, Hamalainen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev. 2014:CD009131.","DOI":"10.1002\/14651858.CD009131.pub3"},{"key":"2555_CR206","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s40263-020-00734-4","volume":"34","author":"MH Chen","year":"2020","unstructured":"Chen MH, Goverover Y, Genova HM, DeLuca J. Cognitive efficacy of pharmacologic treatments in multiple sclerosis: a systematic review. CNS Drugs. 2020;34:599\u2013628.","journal-title":"CNS Drugs"},{"key":"2555_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01772-7","volume":"20","author":"A Feinstein","year":"2020","unstructured":"Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti N, Dalgas U, et al. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx). BMC Neurol. 2020;20:204.","journal-title":"BMC Neurol"},{"key":"2555_CR208","doi-asserted-by":"crossref","unstructured":"He D, Zhang Y, Dong S, Wang D, Gao X, Zhou H. Pharmacological treatment for memory disorder in multiple sclerosis. Cochrane Database Syst Rev. 2013:CD008876.","DOI":"10.1002\/14651858.CD008876.pub3"},{"key":"2555_CR209","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/13651501.2021.1973506","volume":"26","author":"M Sabe","year":"2022","unstructured":"Sabe M, Sentissi O. Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series. Int J Psychiatry Clin Pract. 2022;26:287\u201393.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2555_CR210","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/135245850100700409","volume":"7","author":"JB Boringa","year":"2001","unstructured":"Boringa JB, Lazeron RH, Reuling IE, Ader HJ, Pfennings L, Lindeboom J, et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler. 2001;7:263\u20137.","journal-title":"Mult Scler"},{"key":"2555_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-55","volume":"12","author":"RH Benedict","year":"2012","unstructured":"Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol. 2012;12:55.","journal-title":"BMC Neurol"},{"key":"2555_CR212","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","volume":"16","author":"RH Benedict","year":"2002","unstructured":"Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16:381\u201397.","journal-title":"Clin Neuropsychol"},{"key":"2555_CR213","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2555_CR214","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"2555_CR215","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"2555_CR216","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1176\/ajp.111.5.343","volume":"111","author":"MB Parloff","year":"1954","unstructured":"Parloff MB, Kelman HC, Frank JD. Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy. Am J Psychiatry. 1954;111:343\u201352.","journal-title":"Am J Psychiatry"},{"key":"2555_CR217","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1017\/S0033291700035558","volume":"26","author":"AJ Rush","year":"1996","unstructured":"Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477\u201386.","journal-title":"Psychol Med"},{"key":"2555_CR218","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","volume":"44","author":"JD Henry","year":"2005","unstructured":"Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44:227\u201339.","journal-title":"Br J Clin Psychol"},{"key":"2555_CR219","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18","author":"JD Fisk","year":"1994","unstructured":"Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18:S79\u201383.","journal-title":"Clin Infect Dis"},{"key":"2555_CR220","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121\u20133.","journal-title":"Arch Neurol"},{"key":"2555_CR221","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","volume":"37","author":"JE Schwartz","year":"1993","unstructured":"Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993;37:753\u201362.","journal-title":"J Psychosom Res"},{"key":"2555_CR222","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner IK, Raselli C, Stocklin M, Opwis K, Kappos L, Calabrese P. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15:1509\u201317.","journal-title":"Mult Scler"},{"key":"2555_CR223","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"2555_CR224","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00115-005-1990-x","volume":"77","author":"P Flachenecker","year":"2006","unstructured":"Flachenecker P, Muller G, Konig H, Meissner H, Toyka KV, Rieckmann P. [\"Fatigue\" in multiple sclerosis. Development and and validation of the \"Wurzburger Fatigue Inventory for MS\"]. Der Nervenarzt. 2006;77:165\u20136, 168\u201370. 172\u20134.","journal-title":"Der Nervenarzt"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02555-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T06:15:55Z","timestamp":1689747355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":224,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02555-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MM reports grants and personal fees from Almirall. She was awarded a MAGNIMS-ECTRIMS fellowship in 2020. PP received speaker honoraria from Roche, Biogen, Novartis, Merck Serono, Bristol Myers Squibb and Genzyme; he has received research support from Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla. MAR received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla. She is an Associate Editor for <i>Multiple Sclerosis and Related Disorders<\/i>. MF is the Editor-in-Chief of the <i>Journal of Neurology<\/i>, Associate Editor of <i>Human Brain Mapping<\/i>, <i>Neurological Sciences<\/i>, and <i>Radiology<\/i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}